Ontruzant
Payments companies reported to CMS as associated with Ontruzant. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ontruzant, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ontruzant
These are the largest totals companies reported as associated with Ontruzant. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ben Chue | Seattle, WA | Hematology & Oncology | $212.75 |
| Bao Dao | Dublin, CA | Hematology & Oncology | $193.62 |
| Naixi Chen | Renton, WA | Hematology & Oncology | $176.11 |
| Vu Phan | Los Alamitos, CA | Hematology & Oncology | $167.93 |
| Michael Yen | Santa Cruz, CA | Hematology & Oncology | $155.68 |
| Emile Salloum | Corpus Christi, TX | Hematology & Oncology | $143.01 |
| Shelly Gupta | Dublin, CA | Hematology & Oncology | $131.52 |
| Lalita Pandit | Fountain Valley, CA | Hematology & Oncology | $127.19 |
| Hao Wei Zhang | Los Angeles, CA | Hematology & Oncology | $126.35 |
| Amal Elali | Fountain Valley, CA | Physician Assistant | $123.15 |
Prescribed Ontruzant?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.